Experimental mRNA-based HIV vaccines enter human trials : Healthcare Asia Daily News

March 18, 2022

Biotechnology company Moderna Inc.
(Moderna) has commenced a Phase 1 human trial testing three different mRNA
vaccines that targets HIV (human immunodeficiency virus). The success of the
“safe and highly…

Source: www.healthcareasia.org – Read more